Inventor · disambiguated record
Christopher Schoenherr
Also filed as: SCHOENHERR CHRISTOPHER · SCHOENHERR CHRISTOPHER J
8 granted patents·4 pending applications·71 citations·filing 1995–2025
85Inventor score
Top patents by PatentIndex Score
12 records- 0195US11208458B2Compositions and methods for internalizing enzymesREGENERON PHARMA·Filed 2018·Granted Dec 28, 2021·28 cites·20 claims
- 0284US6824774B2Antibodies that bind neuron restrictive silencer factor proteinsCALIFORNIA INST OF TECHN·Filed 2001·Granted Nov 30, 2004·8 cites·2 claims
- 0381US11419319B2Genetically modified rodent with an inducible ACVR1 mutation in exon 7 that causes ectopic bone formationREGENERON PHARMA·Filed 2019·Granted Aug 23, 2022·2 cites·23 claims
- 0480US2025171520A1Compositions and methods for internalizing enzymesREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0575US6270990B1Neuron-restrictive silencer factor proteinsCALIFORNIA INST OF TECHN·Filed 1996·Granted Aug 7, 2001·21 cites·5 claims
- 0674US12215138B2Compositions and methods for internalizing enzymesREGENERON PHARMA·Filed 2021·Granted Feb 4, 2025·0 cites·24 claims
- 0773US12089576B2Nucleic acids comprising a modified rodent activin a receptor type 1 (Acvr1) geneREGENERON PHARMA·Filed 2022·Granted Sep 17, 2024·0 cites·12 claims
- 0867US2023298698A1Methods and systems for sequence generation and predictionREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0966US5935811ANeuron-restrictive silencer factor nucleic acidsCALIFORNIA INST OF TECHN·Filed 1995·Granted Aug 10, 1999·12 cites·7 claims
- 1065US12252544B2Anti-CD63 antibodies, conjugates, and uses thereofREGENERON PHARMA·Filed 2019·Granted Mar 18, 2025·0 cites·24 claims
- 1163US2025382377A1Anti-cd63 antibodies, conjugates, and uses thereofREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 1247US2020140492A1Tropism-Modified Recombinant Viral Particles and Uses Thereof for the Targeted Introduction of Genetic Material into Human CellsREGENERON PHARMA·Filed 2018·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →